These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 23151854

  • 1. Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction.
    Wang KF, Huang PH, Chiang CH, Hsu CY, Leu HB, Chen JW, Lin SJ.
    Coron Artery Dis; 2013 Jan; 24(1):23-8. PubMed ID: 23151854
    [Abstract] [Full Text] [Related]

  • 2. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
    Wu TC, Leu HB, Lin WT, Lin CP, Lin SJ, Chen JW.
    Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
    [Abstract] [Full Text] [Related]

  • 3. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.
    Huang SS, Huang PH, Chen YH, Sung SH, Chiang KH, Chen JW, Lin SJ.
    Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786
    [Abstract] [Full Text] [Related]

  • 4. High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.
    Herrmann J, Lennon RJ, Barsness GW, Sandhu GS, Gulati R, Best PJ, Sorajja P, Bresnahan JF, Mathew V, Bell MR, Prasad A.
    Circ Cardiovasc Interv; 2012 Dec; 5(6):783-90. PubMed ID: 23212397
    [Abstract] [Full Text] [Related]

  • 5. Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.
    Eldrup N, Kragelund C, Steffensen R, Nordestgaard BG.
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):677-83. PubMed ID: 21194909
    [Abstract] [Full Text] [Related]

  • 6. Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox).
    Cho KH, Jeong MH, Ahn Y, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Seung KB, Park SJ, Korea Acute Myocardial Infarction Registry Investigators.
    Am J Cardiol; 2010 Oct 15; 106(8):1061-8. PubMed ID: 20920639
    [Abstract] [Full Text] [Related]

  • 7. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
    Yasuda S, Miyazaki S, Kinoshita H, Nagaya N, Kanda M, Goto Y, Nonogi H.
    Clin Sci (Lond); 2007 Jan 15; 112(1):43-9. PubMed ID: 16939410
    [Abstract] [Full Text] [Related]

  • 8. High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention.
    Bjerre M, Pedersen SH, Møgelvang R, Lindberg S, Jensen JS, Galatius S, Flyvbjerg A.
    Eur J Prev Cardiol; 2013 Dec 15; 20(6):922-9. PubMed ID: 23613225
    [Abstract] [Full Text] [Related]

  • 9. Baseline serum matrix metalloproteinase-9 level predicts long-term prognosis after coronary revascularizations in stable coronary artery disease.
    Ye ZX, Leu HB, Wu TC, Lin SJ, Chen JW.
    Clin Biochem; 2008 Mar 15; 41(4-5):292-8. PubMed ID: 18067861
    [Abstract] [Full Text] [Related]

  • 10. Midterm follow-up of patients with perioperative myocardial infarction after coronary artery bypass surgery: clinical significance of different treatment strategies.
    Alexiou K, Wilbring M, Koch C, Kappert U, Tugtekin S, Matschke K.
    Thorac Cardiovasc Surg; 2012 Oct 15; 60(7):452-61. PubMed ID: 22547303
    [Abstract] [Full Text] [Related]

  • 11. Microalbuminuria in non-diabetic STEMI: an independent predictor for acute kidney injury.
    Lazzeri C, Valente S, Chiostri M, Picariello C, Attanà P, Gensini GF.
    Scand Cardiovasc J; 2012 Dec 15; 46(6):324-9. PubMed ID: 22694718
    [Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty.
    Kuliczkowski W, Urbaniak J, Hallén J, Woźniak M, Poloński L, Mysiak A, Atar D, Zembala M, Serebruany V.
    Kardiol Pol; 2013 Dec 15; 71(5):453-63. PubMed ID: 23788085
    [Abstract] [Full Text] [Related]

  • 13. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S, Manhenke C, Squire IB, Ng L, Anand I, Dickstein K.
    J Card Fail; 2007 Dec 15; 13(10):843-9. PubMed ID: 18068618
    [Abstract] [Full Text] [Related]

  • 14. Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients.
    Huang CY, Wu TC, Lin WT, Leu HB, Lin CP, Lin SJ, Chen JW.
    Eur J Clin Invest; 2006 Feb 15; 36(2):76-84. PubMed ID: 16436088
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R, Paniccia R, Antonucci E, Gori AM, Fedi S, Giglioli C, Valente S, Prisco D, Abbate R, Gensini GF.
    Am J Cardiol; 2006 Nov 01; 98(9):1156-9. PubMed ID: 17056317
    [Abstract] [Full Text] [Related]

  • 16. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.
    Cardiovasc Revasc Med; 2009 Nov 01; 10(3):144-50. PubMed ID: 19595394
    [Abstract] [Full Text] [Related]

  • 17. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
    Zeng B, Prasan A, Fung KC, Solanki V, Bruce D, Freedman SB, Brieger D.
    Intern Med J; 2005 Jun 01; 35(6):331-5. PubMed ID: 15892761
    [Abstract] [Full Text] [Related]

  • 18. Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction.
    Matsunaga T, Abe N, Kameda K, Hagii J, Fujita N, Onodera H, Kamata T, Ishizaka H, Hanada H, Osanai T, Okumura K.
    Int J Cardiol; 2005 Nov 02; 105(2):203-8. PubMed ID: 16243114
    [Abstract] [Full Text] [Related]

  • 19. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
    Ke D, Zhong W, Fan L, Chen L.
    Coron Artery Dis; 2012 Nov 02; 23(7):497-506. PubMed ID: 22968214
    [Abstract] [Full Text] [Related]

  • 20. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction.
    Isahaya K, Yamada K, Yamatoku M, Sakurai K, Takaishi S, Kato B, Hirayama T, Hasegawa Y.
    J Stroke Cerebrovasc Dis; 2012 Feb 02; 21(2):102-7. PubMed ID: 21215657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.